The G-allele of rs10830963 in MTNR1B Exerts Stage-Specific Effects Across the Trajectory of Type 2 Diabetes: A Multi-State Analysis
Open Access
- 14 August 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (16) , 7855
Abstract
Although the MTNR1B single nucleotide polymorphism rs10830963 has been strongly associated with the onset of type 2 diabetes (T2D), its association with the progression and prognosis of T2D has been understudied. We conducted this prospective analysis based on the UK Biobank cohort study. Microvascular complications (MIC) of T2D in this study included diabetic retinopathy, diabetic neuropathy, and diabetic kidney disease. Macrovascular complications (MAC) of T2D included diabetic coronary artery disease, diabetic cerebrovascular disease, and diabetic peripheral vascular disease. The multi-state model was used to analyze the association between the polymorphism of rs10830963 and the trajectory of T2D. The accelerated failure time (AFT) model was used to assess the association between rs10830963 and the onset of T2D and T2D comorbidities. A total of 283,531 middle- and old-age participants were included. During a median follow-up of 13.7 years, 11,947 participants developed T2D, 1556 participants developed MIC, 1797 participants developed MAC, and 618 participants died. In the additive model, the G risk allele of rs10830963 was significantly associated with an increased risk of the transition from T2D-free to T2D (HR = 1.050, 95% CI: 1.020, 1.079) and a decreased risk of the transition from T2D to MIC (HR = 0.918, 95% CI: 0.850, 0.992), particularly from T2D to diabetic retinopathy (HR = 0.882, 95% CI: 0.782, 0.995). Besides, the G risk allele of rs10830963 accelerated the transition from T2D-free to T2D (Time Ratio [TR] = 0.966, 95% CI: 0.947, 0.986) and slowed down the transition from T2D to MIC (TR = 1.067, 95% CI: 1.030, 1.105). The MTNR1B single nucleotide polymorphism rs10830963 was associated with an increased risk of T2D and a decreased risk of MIC, particularly diabetic retinopathy among T2D individuals. Our results highlight that rs10830963 might play differential roles in the onset and progression of T2D.Keywords
Funding Information
- National Natural Science Foundation of China (82003411, 2024A04J4622)
- Science and Technology Projects in Guangzhou, China (82003411, 2024A04J4622)
This publication has 40 references indexed in Scilit:
- The role of melatonin receptor 1B gene (MTNR1B) in the susceptibility to depression and type 2 diabetes comorbidityGenes & Diseases, 2024
- Enhancement of mitochondrial energy metabolism by melatonin promotes vascularized skeletal muscle regeneration in a volumetric muscle loss modelFree Radical Biology and Medicine, 2023
- Melatonin receptor gene polymorphisms as a risk factor in patients with diabetic peripheral neuropathyDiabetes/Metabolism Research and Reviews, 2022
- Type 2 diabetes is associated with the MTNR1B gene, a genetic bridge between circadian rhythm and glucose metabolism, in a Turkish populationMolecular Biology Reports, 2021
- Late dinner impairs glucose tolerance in MTNR1B risk allele carriers: A randomized, cross-over studyClinical Nutrition, 2018
- Neu-P11, a novel MT1/MT2 agonist, reverses diabetes by suppressing the hypothalamic-pituitary-adrenal axis in ratsEuropean Journal of Pharmacology, 2017
- Increased Melatonin Signaling Is a Risk Factor for Type 2 DiabetesCell Metabolism, 2016
- The mstate package for estimation and prediction in non- and semi-parametric multi-state and competing risks modelsComputer Methods and Programs in Biomedicine, 2010
- Tutorial in biostatistics: competing risks and multi‐state modelsStatistics in Medicine, 2006
- The accelerated failure time model: A useful alternative to the cox regression model in survival analysisStatistics in Medicine, 1992